PR Newswire

PR Newswire
Share

PR Newswire

 •  January 8

Alcyone's proprietary Pulsar™ advanced precision CNS delivery platform utilizes the cerebrospinal fluid dynamics to precision deliver and optimally biodistribute therapeutics to targets of interest in the CNS. The platform includes an intelligent intrathecal infusion system that can be coupled to a specialized multi-port spinal needle or a...

PR Newswire

 •  December 14, 2017

SAN FRANCISCO, Dec. 14, 2017 /PRNewswire/ -- Fluxion Biosciences, a leading developer of automated solutions for cellular analysis in life sciences research and drug discovery, today announced that it has launched a new BioFlux plate for studying infections caused by the long-term use of catheters. The new plates are available immediately. Silicone...

PR Newswire

 •  December 6, 2017

SOMERVILLE, N.J., Nov. 10, 2017 /PRNewswire/ -- Ethicon*, part of the Johnson & Johnson Medical Devices Companies,** announced today that specific Chlorhexidine-impregnated (CGI) dressings have received the strongest evidence-based recommendation in the Centers for Disease Control (CDC) updated guideline on Use of Chlorhexidine Impregnated (CGI)...

PR Newswire

 •  December 4, 2017

Cardiovascular disease (CVD) is the leading cause of death globally. Every year in the US, an estimated 800,000 people will suffer an acute myocardial infarction (MI), or heart attack, and nearly one in five survivors will experience a recurrent cardiovascular event (non-fatal MI, stroke, cardiovascular death) within one year. The majority of these...

PR Newswire

 •  November 14, 2017

Mr. Myron Holubiak, Chief Executive Officer of Citius, commented "We have believed for some time now, that the physical process of inserting and removing CVCs cause patients significant discomfort, and that having an anti-infective solution that could adequately disinfect a CVC thereby avoiding the removal and insertion of a new CVC would be of...

PR Newswire

 •  October 31, 2017

A drug that receives Fast Track designation is eligible for the following: More frequent meetings with FDA to discuss the drug's development plan and ensure collection of appropriate data needed to support drug approval; More frequent written correspondence from FDA about the design of the clinical trials; Priority review to shorten the FDA review...

PR Newswire

 •  September 14, 2017

Merit Medical Systems, a leading manufacturer of proprietary disposable devices and the exclusive distributor of the Surfacer System in Europe, will be sponsoring the symposium titled The Surfacer Inside-Out Access Catheter System: To Restore and Preserve Access in Chronically Occluded Veins. The symposium will take place on Sunday, September 17th...

PR Newswire

 •  July 6, 2017

Centurion has been awarded two Premier group purchasing agreements. In a statement from Centurion: "Centurion's vascular access solutions include CVC Stock™+ Bundles, a new concept in central line insertion trays. The stock tray breaks down into three distinct zones — maximum barrier, catheter insertion, and site protection. Centurion's ability to...

PR Newswire

 •  July 6, 2017

The Global Intravenous (IV) Therapy and Vein Access Market Should Reach $29 Billion by 2021 from $21.6 Billion in 2016 at a CAGR of 6.1%, from 2016 to 2021 Growing emphasis on cost-effectiveness and cost-containment at health care facilities along with technological advances have enabled the safe and effective use of IV therapies. This is driving...

PR Newswire

 •  June 30, 2017

"Our teams have been working diligently to enroll as many infusion center sites as possible in advance of RADICAVA becoming available in the U.S. to ensure the treatment process is as smooth and convenient as possible for physicians and their patients," said Atsushi Fujimoto, President, MT Pharma America. "These efforts are part of our ongoing...